BriaCell Therapeutics BCTX
NASDAQ BCTX
$4.28 +0.20 (+4.90%)
At close: Sep 30, 2026 · 4:00 PM EDT

BriaCell Therapeutics (BCTX) Times Interest Earned (2021 - 2026)

Updated

BriaCell Therapeutics' (BCTX) Times Interest Earned was -257.19 for fiscal Q3 2026 (quarter ended Apr 30, 2026), compared with -171.13 a year earlier.

Analysis

BriaCell Therapeutics (BCTX) Times Interest Earned (2021 - 2026) Analysis & Trends

Over the twelve months ended Apr 30, 2026, BriaCell Therapeutics' Times Interest Earned came in at -480.85; for FY2025 (ended Jul 31, 2025), it came in at -735.68.

  • By fiscal year, Times Interest Earned came in at -15616.90 in FY2022 and -151.34 in FY2021.
  • The fiscal Q3 2026 figure ranks as the lowest quarterly Times Interest Earned since fiscal Q1 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.41
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 10.28
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 7.27
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 5.22
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -42.08
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 BriaCell Therapeutics 31.03 Mn 30.38 Mn - -257.19
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -257.19
Apr 30, 2025 -171.13
Oct 31, 2021 -2,333.82
Jul 31, 2021 -20.54
Apr 30, 2021 -77.01
Jan 31, 2021 -4.15
API Access

BriaCell Therapeutics Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=BCTX&period=max&api_key=YOUR_API_KEY